Breaking News Instant updates and real-time market news.

NKTR

Nektar

$12.29

-0.295 (-2.35%)

13:50
12/01/16
12/01
13:50
12/01/16
13:50

New positions in Nektar Therapeutics upside calls

New positions in Nektar Therapeutics upside calls. May 15s trade across the exchanges for $1.25 to 1.40, including 1K for $1.40 on ISE. It's a customer buyer, according to ISEE data. 5.1K traded total against 86 in open interest. Bullish flow comes a month after earnings were last reported.

  • 14

    Dec

NKTR Nektar
$12.29

-0.295 (-2.35%)

09/30/16
BMUR
09/30/16
INITIATION
Target $23
BMUR
Buy
Nektar assumed with a Buy at Brean Capital
Brean Capital analyst Difei Yang assumed coverage of Nektar Therapeutics with a Buy rating and raised her price target for the shares to $23 from $18. The company has built an "extensive pipeline" from licensing and partnership deals, Yang tells investors in a research note.
09/30/16
PIPR
09/30/16
NO CHANGE
Target $25
PIPR
Overweight
Piper's Schimmer found Nektar validation at Celgene event
Piper Jaffray analyst Joshua Schimmer says Celgene's (CELG) analyst event provided "another indirect validation" of Nektar Therapeutics' (NKTR) oncology approach. Celgene surprisingly implicated IL-2 as one of the primary mechanisms of Revlimid, Schimmer tells investors in a research note. He views the development as supporting his "enthusiastic outlook" for NKTR-214, the company's long-acting IL-2 targeting Teffector cells. The analyst reiterates an Overweight rating on Nektar with a $25 price target.
11/04/16
PIPR
11/04/16
NO CHANGE
Target $25
PIPR
Overweight
Investors should 'definitely own' Nektar after pullback, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Nektar Therapeutics has moved from a company investors "should definitely know about" to one they "should definitely own" following the recent weakness in the shares. Nektar's partnered commercial products continue to provide stable revenue, Schimmer tells investors in a post-earnings research note. He keeps an Overweight rating on the shares with a $25 price target.
11/08/16
AGIS
11/08/16
INITIATION
Target $21
AGIS
Buy
Nektar initiated with a Buy at Aegis
Aegis analyst Difei Yang initiated Nektar with a Buy and a $21 price target.

TODAY'S FREE FLY STORIES

SLB

Schlumberger

$76.37

-0.84 (-1.09%)

08:06
01/19/18
01/19
08:06
01/19/18
08:06
Hot Stocks
Schlumberger to exit marine and land seismic acquisition market »

Earlier, Schlumberger CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

KSU

Kansas City Southern

$111.50

0.69 (0.62%)

08:05
01/19/18
01/19
08:05
01/19/18
08:05
Earnings
Kansas City Southern reports Q4 EPS $1.38 ex-items, consensus $1.37 »

Reports Q4 revenue $660M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AVGR

Avinger

$0.21

0.0056 (2.79%)

08:05
01/19/18
01/19
08:05
01/19/18
08:05
Hot Stocks
Avinger granted continued listing decision from Nasdaq »

Avinger announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSRR

Sierra Bancorp

$27.66

-0.31 (-1.11%)

08:03
01/19/18
01/19
08:03
01/19/18
08:03
Hot Stocks
Sierra Bancorp increases dividend 14% to 16c »

Sierra Bancorp, parent of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALBO

Albireo Pharma

$29.47

1.46 (5.21%)

08:03
01/19/18
01/19
08:03
01/19/18
08:03
Hot Stocks
Albireo Pharma to receive over $55M in nondilutive cash payments »

Albireo Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMAN

eMagin

08:03
01/19/18
01/19
08:03
01/19/18
08:03
Earnings
eMagin reports preliminary Q4 revenue $6.2M-$6.4M, consensus $5.77M »

Compared to the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUN

Huntsman

$34.28

0.12 (0.35%)

08:03
01/19/18
01/19
08:03
01/19/18
08:03
Initiation
Huntsman initiated  »

Huntsman initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZAYO

Zayo Group

$35.63

-0.95 (-2.60%)

08:02
01/19/18
01/19
08:02
01/19/18
08:02
Hot Stocks
Zayo Group acquires Optic Zoo Networks for C$31M »

Zayo Group Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

MA

MasterCard

$165.48

1.16 (0.71%)

08:02
01/19/18
01/19
08:02
01/19/18
08:02
Recommendations
MasterCard analyst commentary  »

MasterCard price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

QCOM

Qualcomm

$68.05

0.03 (0.04%)

, NXPI

NXP Semiconductors

$120.00

0.66 (0.55%)

08:01
01/19/18
01/19
08:01
01/19/18
08:01
Hot Stocks
Elliott: Qualcomm can deliver value at prices for NXP higher than $135/share »

Elliott Advisors, which…

QCOM

Qualcomm

$68.05

0.03 (0.04%)

NXPI

NXP Semiconductors

$120.00

0.66 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TEAM

Atlassian

$55.60

0.73 (1.33%)

08:01
01/19/18
01/19
08:01
01/19/18
08:01
Recommendations
Atlassian analyst commentary  »

Atlassian weakness would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

08:00
01/19/18
01/19
08:00
01/19/18
08:00
Recommendations
Amazon.com analyst commentary  »

Amazon doesn't look…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 01

    Feb

  • 18

    Mar

NEM

Newmont Mining

$39.24

-0.21 (-0.53%)

08:00
01/19/18
01/19
08:00
01/19/18
08:00
Options
Newmont Mining put buyer realizes 16% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CS

Credit Suisse

$18.93

0.21 (1.12%)

07:59
01/19/18
01/19
07:59
01/19/18
07:59
Periodicals
Credit Suisse's top China dealmaker set to leave, Bloomberg reports »

Mervyn Chow, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

LSXMA

Liberty SiriusXM

$40.83

0.29 (0.72%)

07:59
01/19/18
01/19
07:59
01/19/18
07:59
Initiation
Liberty SiriusXM initiated  »

Liberty SiriusXM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$41.30

0.1 (0.24%)

, BSFT

BroadSoft

$55.00

0.05 (0.09%)

07:57
01/19/18
01/19
07:57
01/19/18
07:57
Conference/Events
BroadSoft to host special shareholder meeting »

Special Shareholder…

CSCO

Cisco

$41.30

0.1 (0.24%)

BSFT

BroadSoft

$55.00

0.05 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBT

BB&T

$54.14

0.86 (1.61%)

07:55
01/19/18
01/19
07:55
01/19/18
07:55
Recommendations
BB&T analyst commentary  »

BB&T price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$92.97

0.8 (0.87%)

07:54
01/19/18
01/19
07:54
01/19/18
07:54
Periodicals
Turner, Warner Bros. to launch FilmStruck internationally, Variety reports »

Turner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANAB

AnaptysBio

$110.45

-1.11 (-0.99%)

07:54
01/19/18
01/19
07:54
01/19/18
07:54
Recommendations
AnaptysBio analyst commentary  »

AnaptysBio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$99.86

-0.9 (-0.89%)

07:53
01/19/18
01/19
07:53
01/19/18
07:53
Recommendations
American Express analyst commentary  »

Credit Suisse keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$18.95

0.09 (0.48%)

07:50
01/19/18
01/19
07:50
01/19/18
07:50
Upgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$232.12

0.75 (0.32%)

07:49
01/19/18
01/19
07:49
01/19/18
07:49
Initiation
Becton Dickinson initiated  »

Becton Dickinson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

TSM

TSMC

$44.57

1.44 (3.34%)

07:48
01/19/18
01/19
07:48
01/19/18
07:48
Periodicals
TSMC sees revenue growth of 10%-15% in 2018, DigiTimes reports »

Taiwan Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$45.28

2.31 (5.38%)

07:48
01/19/18
01/19
07:48
01/19/18
07:48
Downgrade
WNS Holdings rating change  »

WNS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$90.10

-0.04 (-0.04%)

07:47
01/19/18
01/19
07:47
01/19/18
07:47
Recommendations
Microsoft analyst commentary  »

Microsoft cloud margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

  • 07

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.